Transcripts
Lantern Pharma (LTRN) earnings call transcripts
Earnings call transcripts for Lantern Pharma Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
The call reframed Lantern as two capital-efficient growth engines, with LP300 refinement and Open Medicine AI commercialization driving the next phase.
Aug 14, 2026Confident0.78